<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05046470</url>
  </required_header>
  <id_info>
    <org_study_id>2020/16NOV/552</org_study_id>
    <nct_id>NCT05046470</nct_id>
  </id_info>
  <brief_title>SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonie - Bruxelles: An Epidemiological Pilot Study</brief_title>
  <acronym>DYNAtracs</acronym>
  <official_title>SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonie - Bruxelles: An Epidemiological Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Université Catholique de Louvain</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Liege</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Libre de Bruxelles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Université Catholique de Louvain</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators hypothesize that children are less likely to become infected in the school&#xD;
      environment, compared to the household or outside the school setting. Primary schools do not&#xD;
      play a major role in SARS-CoV-2 spreading. They hypothesize that incidence level in schools&#xD;
      is mainly a consequence of community transmission. The incidence level in household and that&#xD;
      the secondary attack rate in schools remains at least 5 times lower that the transmission&#xD;
      level in households.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 14, 2021</start_date>
  <completion_date type="Anticipated">January 14, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 14, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infection of a child with SARS-CoV-2 secondary to a classmate</measure>
    <time_frame>6 weeks</time_frame>
    <description>Time varying number and proportion of children infected with SARS-CoV-2 secondary to an asymptomatic infected classmate (transmission rate inside school with the child being the infector).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infection of an adult school-attender with SARS-CoV-2 secondary to an infected child</measure>
    <time_frame>6 weeks</time_frame>
    <description>Time varying number and proportion of adult school-attenders infected with SARS-CoV-2 secondary to an asymptomatic infected child (transmission rate inside school but from a child to an adult).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infection of a child with SARS-CoV-2 secondary to an adult school attender</measure>
    <time_frame>6 weeks</time_frame>
    <description>Time varying number and proportion of children infected with SARS-CoV-2 secondary to an infected adult school-attender (transmission rate inside school but from an adult to a child)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infection of a child with SARS-CoV-2 secondary to a contact outside the school, including the household</measure>
    <time_frame>6 weeks</time_frame>
    <description>Time varying number and proportion of children infected with SARS-CoV-2 secondary to a household contact or outside the school (transmission rate from in community).</description>
  </primary_outcome>
  <enrollment type="Anticipated">2900</enrollment>
  <condition>SARS-CoV-2 Infection</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Saliva samples&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All Belgian primary schools of the Federation Wallonie - Bruxelles that have organized a&#xD;
        full resumption of school activities with the control measures recommended by the&#xD;
        government, are eligible for the study.&#xD;
&#xD;
        Twelve schools were chosen by purposive criteria: either high (≥2 classes per grade) or low&#xD;
        size of the school, a school within an area with either a high or a low incidence of&#xD;
        SARS-CoV-2 during April 2020, the first wave of covid-19 in Belgium, and a school with&#xD;
        either a high or a low socioeconomic level (Belgian 20-point-scale ISE idex &gt;14 or &lt;6).&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All children and school attenders from selected schools was invited to participate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to provide written informed consent before enrolment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Annie Robert, Pr</last_name>
    <role>Study Director</role>
    <affiliation>Université Catholique de Louvain</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Annie Robert, Pr</last_name>
    <phone>+32 2 764 33 21</phone>
    <email>annie.robert@uclouvain.be</email>
  </overall_contact>
  <location>
    <facility>
      <name>UCLouvain</name>
      <address>
        <city>Brussels</city>
        <zip>1200</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Annie Robert, Pr</last_name>
      <phone>+32 2 764 33 21</phone>
      <email>annie.robert@uclouvain.be</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>https://www.sesa.ucl.ac.be/Dynatracs/assets/pdf/1011_ChildrenTransmission_Protocol_Ver1.0_10NOV20.pdf</url>
    <description>Protocol</description>
  </link>
  <link>
    <url>https://www.sesa.ucl.ac.be/Dynatracs/</url>
    <description>Study website</description>
  </link>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>September 7, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 16, 2021</study_first_posted>
  <last_update_submitted>September 15, 2021</last_update_submitted>
  <last_update_submitted_qc>September 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Primary Schools</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected IPD</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Starting 6 months after publication</ipd_time_frame>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>November 10, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/70/NCT05046470/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

